Latest Breaking News On - Disc medicine reports first quarter - Page 1 : comparemela.com

Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic. | May 15, 2023

Suzanne messereJohn quiselExchange commissionVerge scientific communicationsCongress onEuropean hematology associationBain capital life sciencesDisc medicine incDevelopment expensesDisc medicine reports first quarterProvides businessMabwell therapeuticsBain capital lifeChief executive officerBusiness highlightsUpcoming milestones